Claire C J Dekkers (Claire Cj Dekkers)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Diabetic Nephropathy

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Taha Sen, Rosalie A Scholtes, Peter J Greasley, David Z I Cherney, Claire C J Dekkers, Marc G Vervloet, Alexander H J Danser, Sean J Barbour, Cecilia Karlsson, Ann Hammarstedt, Qiang Li, Gozewijn D Laverman, Petter Bjornstad, Daniel H van Raalte, Hiddo J Lambers Heerspink
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND. Diabetes, obesity & metabolism 24 (8) (2022)
Jasper Stevens, Mireille A Wessels, Jan Roggeveld, Remco A Koster, Claire C J Dekkers, Maaike K van Gelder, Ron T Gansevoort, Hiddo J Lambers Heerspink, Daniel J Touw
UHPLC-MS/MS method for iohexol determination in human EDTA and lithium-heparin plasma, human urine and in goat- and pig EDTA plasma. Bioanalysis 12 (14) (2020)
Claire C J Dekkers, C David Sjöström, Peter J Greasley, Valerie Cain, David W Boulton, Hiddo J Lambers Heerspink
Effects of the sodium-glucose co-transporter-2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes. Diabetes, obesity & metabolism 21 (12) (2019)
Claire C J Dekkers, Sergei Petrykiv, Gozewijn D Laverman, David Z Cherney, Ron T Gansevoort, Hiddo J Lambers Heerspink
Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers. Diabetes, obesity & metabolism 20 (8) (2018)